Scorpion venom to fight brain cancer

Scientists have received approval from the US Food and Drug Administration (FDA) to use "Tumour Paint", a product derived from scorpion venom for study in human trials in the US, in an effort to treat people suffering from brain cancer.

Paralysis treatment: Leading avenues of research

Stem cells are immature cells that grow into the specialised cells that comprise the body`s tissue. The aim is to coax these cells into becoming nerve cells to replenish those damaged in spinal injury.

New high-tech device can help atrial fibrillation sufferers

Doctors at Loyola University Medical Center in Illinois, have used a new high-tech catheter device that can improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat.

India raises concerns over FDA actions on domestic drug firms

India today raised serious concerns over the USFDA`s audit inspections of Indian pharma companies and `disproportionate penalties` in some instances and said it would submit a discussion document on the issues to the US.

US fertility clinic mix-up brings calls, questions

The suspect is dead, the fertility clinic where he reportedly replaced a customer`s sperm with his own no longer operates, and the clinic left no records that might show the extent of the scandal, the University of Utah said today.

Lupin launches HIV drug in the US with marketing exclusivity

Drug major Lupin Wednesday said it has launched the generic version of ViiV Healthcare`s (ViiV) Trizivir tablets in the US market with 180-days of marketing exclusivity.

US calls for safety review of antibacterial soaps

In response to health concerns over the widespread use of antibacterial soaps, US manufacturers will soon have to meet stricter requirements showing long-term safety, regulators said Monday.

Eighth Princeton student diagnosed with meningitis

An eighth Princeton University student has been diagnosed with meningitis, a potentially fatal infection that causes swelling of the brain and spinal cord, a university spokesman said on Friday.

FDA seeks to ban trans fats in processed foods due to health risks

The U.S. Food and Drug Administration on Thursday proposed banning artificial trans fats in processed food ranging from cookies to frozen pizza, citing the risk of heart disease.

`Ranbaxy got USFDA nod with no data or fraudulent data`

India`s drug major Ranbaxy Laboratories used "fraudulent" data to get USFDA nod to sell its generic drugs, according to whistleblower Dinesh Thakur, who has also accused the drug-maker of faking test results.

New drug policy, regulations slowing down pharma growth: Report

Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 per cent in 2013 as compared to 16.6 per cent in 2012.

US approves more powerful, pure hydrocodone drug

The US Food and Drug Administration has approved a stronger, single-ingredient version hydrocodone, the widely-abused prescription painkiller.

Jubilant receives USFDA approval for two generic drugs

Drug firm Jubilant Life Sciences Ltd Friday said it has received approval from the US Food and Drugs Administration (USFDA) to market generic versions of GlaxoSmithKline`s anti-depressant Wellbutrin SR and smoking cessation aid, Zyban.

Now, online database of disease genes that could be targeted with drugs

Researchers have created a comprehensive database that matches thousands of disease genes with approved or experimental drugs that target those genes.

Glenmark gets USFDA nod for skin infections cream

Glenmark Pharmaceuticals today said it has received approval from the US health regulator for its generic Hydrocortisone Butyrate Cream used for treating variety of skin infections.

Ranbaxy import ban: USFDA found suspected hair, oil in tablets

Tablets embedded with `black fibre` that was suspected to be hair from an employee`s arm, `black spots` of oil from machines in tablets and absence of running water in toilets were some observations made by USFDA that has banned import of drugs made at Ranbaxy`s Mohali unit.

Sun Pharma gets USFDA nod for generic duodenal ulcer capsules

Drug firm Sun Pharmaceutical Industries today said it has received final approval from the US health regulator for its generic Lansoprazole delayed- release capsules used for treating duodenal ulcer.

Lupin receives USFDA nod for Rifampin Capsules

Pharma major Lupin Limited Friday announced that its US-based subsidiary Lupin Pharmaceuticals, Inc has got approval from the US health regulator to sell a generic version of Sanofi Aventis’ Rifadin capsules, used to treat tuberculosis, in the American market.

Novartis muscle wasting drug gets `breakthrough` status

Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion body myositis (sIBM).

Glenmark gets USFDA nod for alcohol abstinence drug

Glenmark Pharmaceuticals today said it has received US health regulator`s approval to market generic version of Forest Laboratories` Campral Delayed Release Tablets, a drug used for alcohol abstinence, in the American market.